Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | thyroid hormone receptor, beta | Starlite/ChEMBL | No references |
Homo sapiens | tumor protein p53 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Brugia malayi | photoreceptor-specific nuclear receptor | thyroid hormone receptor, beta | 461 aa | 414 aa | 24.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.2682 | 1 | 0.5 |
Echinococcus multilocularis | hydroxymethylglutaryl coenzyme A reductase | 0.2682 | 1 | 1 |
Echinococcus multilocularis | tumor protein p63 | 0.0408 | 0.1389 | 0.1012 |
Schistosoma mansoni | hypothetical protein | 0.0152 | 0.042 | 0.042 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.1104 | 0.4025 | 0.3763 |
Echinococcus multilocularis | sterol regulatory element binding protein | 0.1104 | 0.4025 | 0.3763 |
Brugia malayi | CHE-14 protein | 0.1104 | 0.4025 | 0.4025 |
Echinococcus granulosus | tumor protein p63 | 0.0408 | 0.1389 | 0.1012 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.1258 | 0.4609 | 1 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0833 | 0.3 | 0.2693 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.1258 | 0.4609 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0072 | 0.0072 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 0.3 | 0.2693 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.2682 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.007 | 0.007 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.0796 | 0.0796 |
Schistosoma mansoni | thyroid hormone receptor | 0.0164 | 0.0466 | 0.0466 |
Echinococcus granulosus | hydroxymethylglutaryl coenzyme A reductase | 0.2682 | 1 | 1 |
Schistosoma mansoni | patched 1 | 0.1104 | 0.4025 | 0.4025 |
Loa Loa (eye worm) | hypothetical protein | 0.1104 | 0.4025 | 0.4025 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 0.3 | 0.3 |
Loa Loa (eye worm) | abnormal chemotaxis protein 14 | 0.1104 | 0.4025 | 0.4025 |
Giardia lamblia | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0.1258 | 0.4609 | 0.5 |
Mycobacterium ulcerans | hydroxymethylglutaryl-coenzyme a (HMG-CoA) reductase | 0.2682 | 1 | 0.5 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.1258 | 0.4609 | 1 |
Schistosoma mansoni | hydroxymethylglutaryl-CoA reductase (NADPH) | 0.2682 | 1 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0072 | 0.0072 |
Onchocerca volvulus | 0.0286 | 0.0927 | 1 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.1104 | 0.4025 | 0.8415 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0072 | 0.0072 |
Leishmania major | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.2682 | 1 | 0.5 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0164 | 0.0466 | 0.0048 |
Echinococcus granulosus | sterol regulatory element binding protein | 0.1104 | 0.4025 | 0.3763 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0072 | 0.0072 |
Echinococcus multilocularis | protein patched | 0.1104 | 0.4025 | 0.3763 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.1104 | 0.4025 | 0.4025 |
Echinococcus granulosus | Protein patched homolog 1 | 0.1104 | 0.4025 | 0.3763 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.0796 | 0.0796 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.2682 | 1 | 0.5 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.1104 | 0.4025 | 0.3763 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.006 | 0.007 | 0.007 |
Loa Loa (eye worm) | hypothetical protein | 0.2682 | 1 | 1 |
Echinococcus multilocularis | protein dispatched 1 | 0.1104 | 0.4025 | 0.3763 |
Schistosoma mansoni | thyroid hormone receptor | 0.0164 | 0.0466 | 0.0466 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 1.4125 um | PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 7.9433 um | PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (binding) | = 10 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 32.6427 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.